Rafael Duarte Selected Research

Rafael Duarte Research Topics

Disease

9	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2023 - 02/2012
5	COVID-19 01/2024 - 10/2020
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2020 - 01/2012
4	Hematologic Neoplasms (Hematological Malignancy) 01/2024 - 10/2014
4	Infections 01/2023 - 10/2018
3	Neoplasms (Cancer) 10/2020 - 02/2010
3	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 01/2020 - 01/2018
2	Leukemia 06/2017 - 01/2016
2	Lymphoma (Lymphomas) 09/2016 - 02/2012
2	Bronchiolitis Obliterans Syndrome 01/2016 - 07/2010
1	Febrile Neutropenia 01/2024
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2024
1	Primary Myelofibrosis (Myelosclerosis) 01/2023
1	Heart Failure 01/2022
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2020
1	Aplastic Anemia (Anemia, Hypoplastic) 10/2019
1	Thrombocytopenia (Thrombopenia) 01/2019
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2018
1	Multiple Myeloma 09/2016
1	Iron Overload 10/2014
1	Residual Neoplasm 09/2013
1	Pneumonia (Pneumonitis) 12/2012
1	Hodgkin Disease (Hodgkin's Disease) 02/2012
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2010
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2006

Drug/Important Bio-Agent (IBA)

2	SteroidsIBA 01/2023 - 01/2022
2	Antiviral Agents (Antivirals)IBA 10/2020 - 10/2018
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2016 - 02/2012
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2012 - 02/2010
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2024
1	remdesivirIBA 01/2024
1	N-(2-cyanoethylene)urea (BA 1)IBA 01/2024
1	nirmatrelvir and ritonavir drug combinationIBA 01/2024
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 01/2024
1	Janus Kinase InhibitorsIBA 01/2023
1	ruxolitinibIBA 01/2023
1	Immunomodulating AgentsIBA 01/2023
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2023
1	Thalidomide (Thalomid)FDA Link 01/2023
1	Dacarbazine (DIC)FDA LinkGeneric 01/2022
1	tocilizumab (atlizumab)FDA Link 01/2022
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2022
1	Antineoplastic Agents (Antineoplastics)IBA 10/2020
1	Monoclonal AntibodiesIBA 10/2020
1	Thrombopoietin (c-mpl Ligand)IBA 10/2019
1	Thrombopoietin ReceptorsIBA 01/2019
1	Phosphotransferases (Kinase)IBA 10/2018
1	Dasatinib (BMS 354825)FDA Link 10/2018
1	Tyrosine Kinase InhibitorsIBA 10/2018
1	CytokinesIBA 10/2018
1	Tyrosine (L-Tyrosine)FDA Link 10/2018
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 09/2016
1	plerixafor FDA Link 09/2016
1	Immunoglobulins (Immunoglobulin)IBA 01/2016
1	MicroRNAs (MicroRNA)IBA 10/2015
1	Long Noncoding RNAIBA 10/2015
1	Ferritins (Ferritin)IBA 10/2014
1	Deferasirox FDA Link 10/2014
1	Alanine Transaminase (SGPT)IBA 10/2014
1	IronIBA 10/2014
1	Core Binding Factors (Core-Binding Factor)IBA 09/2013
1	DNA (Deoxyribonucleic Acid)IBA 09/2013
1	14-thioglycolamido-7,8-dihydromorphinone (TAMO)IBA 02/2012
1	AntigensIBA 02/2012
1	AnthracyclinesIBA 01/2012
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2012
1	beta-Lactamases (beta-Lactamase)IBA 02/2010
1	fludarabineIBA 01/2006

Therapy/Procedure

10	Cell Transplantation 03/2021 - 01/2006
6	Transplantation 08/2021 - 07/2010
5	Hematopoietic Stem Cell Transplantation 08/2021 - 01/2016
5	Drug Therapy (Chemotherapy) 10/2020 - 07/2010
4	Therapeutics 01/2024 - 02/2012
4	Stem Cell Transplantation 01/2024 - 07/2010
4	Activities of Daily Living (ADL) 01/2019 - 01/2019
2	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 08/2021 - 01/2016
1	Cell- and Tissue-Based Therapy (Cell Therapy) 08/2021
1	Homologous Transplantation 02/2012
1	Induction Chemotherapy 01/2012